We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current HVO market cap is 116.11M. The company's latest EPS is EUR 0.0155 and P/E is 10.81.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 20.6M | 36.86M | 48.48M | 56.04M | 62.73M |
| Operating Income | -10.61M | 492k | 5.98M | 10.09M | 12.83M |
| Net Income | -10.79M | -74k | -776k | 16.12M | 10.65M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 48.55M | 42.27M | 51.38M | 83.23M | 88.89M |
| Total Liabilities | 26.25M | 21.59M | 31.16M | 48.9M | 44.22M |
| Total Equity | 22.3M | 20.68M | 20.22M | 34.33M | 44.68M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 4.17M | -1.56M | 15.98M | 17.24M | 10.34M |
| Investing | 1.18M | -739k | -1.36M | -5.18M | -660k |
| Financing | 13.04M | -1.2M | -1.83M | -3.52M | -2.41M |
| Market Cap | 116.11M |
| Price to Earnings Ratio | 10.81 |
| Price to Sales Ratio | 1.83 |
| Price to Cash Ratio | 2.6 |
| Price to Book Ratio | 2.58 |
| Dividend Yield | 1.18% |
| Shares Outstanding | 687.01M |
| Average Volume (1 week) | 664.63k |
| Average Volume (1 Month) | 1.15M |
| 52 Week Change | -36.23% |
| 52 Week High | 30.75 |
| 52 Week Low | 12.60 |
| Spread (Intraday) | 0.5 (2.94%) |
| Company Name | Hvivo Plc |
| Address |
floor 24 london E14 5NR |
| Website | https://www.hvivo.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
